Taken together, V2R antagonists bear therapeutic potential as a part of DKD treatment strategy but their pronounced diuretic action and certain hepatotoxicity may limit patient compliance and complicate the long-term application in chronic kidney disorders such as DKD or CKD (61). Here, AVPR2 is linked to diabetic kidney disease.